Suchergebnisse - "Kameyama, Koji"

PubPharm (39)

1

Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer

enthalten in: Cancer genomics & proteomics | 2024

von Mizutani, K. | Sugiyama, S. | Kameyama, K. | +17

2

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma : A Multicenter Retrospective Real-World Cohort Study

enthalten in: Cancers | 2023

von Iinuma, K. | Yamada, T. | Kameyama, K. | +14

3

Evaluation of physical and psychological status of health care workers infected with COVID-19 during a hospital outbreak in Japan

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Kameyama, K. | Mizutani, K. | Miyake, Y. | +6

4

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma : A Multicenter Retrospective Cohort Study

enthalten in: Biomedicines | 2022

von Iinuma, K. | Tomioka-Inagawa, R. | Kameyama, K. | +13

5

Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential VHL Mutations Underlie Multifocal ccRCC

enthalten in: Cancer genomics & proteomics | 2022

von Mizutani, K. | Yokoi, S. | Sawada, S. | +11

6

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma : A Multicenter, Retrospective Cohort Study

enthalten in: Cancers | 2022

von Iinuma, K. | Kameyama, K. | Taniguchi, T. | +12

7

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Kawase, M. | Takagi, K. | Kawada, K. | +14

8

A Case of Metastasis of Gastric Cancer to the Bladder

enthalten in: Hinyokika kiyo. Acta urologica Japonica | 2021

von Kameyama, K. | Toyota, S. | Kamei, S. | +5

9

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab

enthalten in: Journal of clinical medicine | 2021

von Iinuma, K. | Enomoto, T. | Kawada, K. | +13

10

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma : A Multicenter Retrospective Cohort Study

enthalten in: Current oncology (Toronto, Ont.) | 2021

von Iinuma, K. | Kameyama, K. | Kawada, K. | +12